{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:01:47Z","timestamp":1791892907936,"version":"4.3.4"},"reference-count":96,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI164590"],"award-info":[{"award-number":["AI164590"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI007019"],"award-info":[{"award-number":["AI007019"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["25POST1378255"],"award-info":[{"award-number":["25POST1378255"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003157","name":"Myasthenia Gravis Foundation of America Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003157","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS120496"],"award-info":[{"award-number":["NS120496"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS130831"],"award-info":[{"award-number":["NS130831"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI114780"],"award-info":[{"award-number":["AI114780"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.cell.2025.03.004","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T17:41:43Z","timestamp":1744134103000},"page":"2390-2406.e20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Autoimmune mechanisms elucidated through muscle acetylcholine receptor structures"],"prefix":"10.1016","volume":"188","author":[{"given":"Huanhuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh C.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen M.","family":"Noviello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4283-1147","authenticated-orcid":false,"given":"Ryan E.","family":"Hibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2025.03.004_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00441-006-0237-x","article-title":"Development of the neuromuscular junction","volume":"326","author":"Witzemann","year":"2006","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.cell.2025.03.004_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1474-4422(21)00357-4","article-title":"Advances in the understanding of disease mechanisms of autoimmune neuromuscular junction disorders","volume":"21","author":"Huijbers","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cell.2025.03.004_bib3","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3389\/fimmu.2020.00776","article-title":"Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology","volume":"11","author":"Fichtner","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2025.03.004_bib4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fimmu.2020.00212","article-title":"Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics","volume":"11","author":"Lazaridis","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2025.03.004_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/nyas.13522","article-title":"Myasthenia gravis: the role of complement at the neuromuscular junction","volume":"1412","author":"Howard","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cell.2025.03.004_bib6","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.4049\/jimmunol.167.4.1935","article-title":"Somatic Hypermutation and Selection of B Cells in Thymic Germinal Centers Responding to Acetylcholine Receptor in Myasthenia Gravis1","volume":"167","author":"Sims","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.cell.2025.03.004_bib7","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00401-022-02493-6","article-title":"Receptor clustering and pathogenic complement activation in myasthenia gravis depend on synergy between antibodies with multiple subunit specificities","volume":"144","author":"Rose","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cell.2025.03.004_bib8","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jamaneurol.2019.5125","article-title":"Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial","volume":"77","author":"Howard","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.cell.2025.03.004_bib9","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study","volume":"16","author":"Howard","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cell.2025.03.004_bib10","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S1474-4422(21)00159-9","article-title":"Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Howard","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cell.2025.03.004_bib11","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/acn3.51376","article-title":"Long-term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analyses","volume":"8","author":"Howard","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.cell.2025.03.004_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00401-023-02603-y","article-title":"Individual myasthenia gravis autoantibody clones can efficiently mediate multiple mechanisms of pathology","volume":"146","author":"Pham","year":"2023","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cell.2025.03.004_bib13","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/s41586-024-07774-6","article-title":"Structural switch in acetylcholine receptors in developing muscle","volume":"632","author":"Li","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.cell.2025.03.004_bib14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/321406a0","article-title":"Molecular distinction between fetal and adult forms of muscle acetylcholine receptor","volume":"321","author":"Mishina","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.cell.2025.03.004_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrn731","article-title":"Emerging structure of the Nicotinic Acetylcholine receptors","volume":"3","author":"Karlin","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.cell.2025.03.004_bib16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-biochem-030122-033116","article-title":"The Nicotinic Acetylcholine Receptor and Its Pentameric Homologs: Toward an Allosteric Mechanism of Signal Transduction at the Atomic Level","volume":"93","author":"Cecchini","year":"2024","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.cell.2025.03.004_bib17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.neuron.2019.07.030","article-title":"Agonist Selectivity and Ion Permeation in the \u03b13\u03b24 Ganglionic Nicotinic Receptor","volume":"104","author":"Gharpure","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.cell.2025.03.004_bib18","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.neuron.2020.03.012","article-title":"Structure of the Native Muscle-type Nicotinic Receptor and Inhibition by Snake Venom Toxins","volume":"106","author":"Rahman","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.cell.2025.03.004_bib19","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.neuron.2022.01.013","article-title":"Conformational transitions and ligand-binding to a muscle-type nicotinic acetylcholine receptor","volume":"110","author":"Zarkadas","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.cell.2025.03.004_bib20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1017\/S0033583513000061","article-title":"Nicotinic acetylcholine receptor and the structural basis of neuromuscular transmission: insights from Torpedo postsynaptic membranes","volume":"46","author":"Unwin","year":"2013","journal-title":"Q.\u00a0Rev. Biophys."},{"key":"10.1016\/j.cell.2025.03.004_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-32174-7","article-title":"The molecular mechanism of snake short-chain \u03b1-neurotoxin binding to muscle-type nicotinic acetylcholine receptors","volume":"13","author":"Nys","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2025.03.004_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-38827-5","article-title":"Structural interplay of anesthetics and paralytics on muscle nicotinic receptors","volume":"14","author":"Goswami","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2025.03.004_bib23","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/(SICI)1097-4547(19960815)45:4<492::AID-JNR20>3.0.CO;2-1","article-title":"Evidence against chronic antigen-specific T lymphocyte activation in myasthenia gravis","volume":"45","author":"Infante","year":"1996","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.cell.2025.03.004_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0165-5728(97)00147-1","article-title":"Highly purified oligo-His tagged human recombinant \u03b11-AChR is immunogenic in\u00a0vivo and suitable for T\u00a0cell stimulation in\u00a0vitro in experimental and human myasthenia gravis","volume":"80","author":"Voltz","year":"1997","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.cell.2025.03.004_bib25","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s12192-023-01395-0","article-title":"Recombinant cellular model system for human muscle-type nicotinic acetylcholine receptor \u03b112\u03b21\u03b4\u03b5","volume":"28","author":"Brockm\u00f6ller","year":"2023","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.cell.2025.03.004_bib26","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s11010-024-05032-x","article-title":"Protein networking: nicotinic acetylcholine receptors and their protein\u2013protein-associations","volume":"479","author":"Brockm\u00f6ller","year":"2024","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cell.2025.03.004_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084791","article-title":"Expression of a Highly Antigenic and Native-Like Folded Extracellular Domain of the Human \u03b11 Subunit of Muscle Nicotinic Acetylcholine Receptor, Suitable for Use in Antigen Specific Therapies for Myasthenia Gravis","volume":"8","author":"Niarchos","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cell.2025.03.004_bib28","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.1365-2249.1997.4701367.x","article-title":"Expression of human\u2013Torpedo hybrid acetylcholine receptor (AChR) for analysing the subunit specificity of antibodies in sera from patients with myasthenia gravis (MG)","volume":"109","author":"Loutrari","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cell.2025.03.004_bib29","doi-asserted-by":"crossref","first-page":"12757","DOI":"10.1016\/S0021-9258(18)33577-4","article-title":"Purification and biochemical characterization of nicotinic acetylcholine receptors of human muscle","volume":"257","author":"Momoi","year":"1982","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cell.2025.03.004_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1432-1033.1993.tb18027.x","article-title":"Primary structure of the human muscle acetylcholine receptor. cDNA cloning of the gamma and epsilon subunits","volume":"215","author":"Beeson","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.cell.2025.03.004_bib31","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41594-022-00737-3","article-title":"Structural mechanism of muscle nicotinic receptor desensitization and block by curare","volume":"29","author":"Rahman","year":"2022","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.cell.2025.03.004_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-46028-x","article-title":"A release of local subunit conformational heterogeneity underlies gating in a muscle nicotinic acetylcholine receptor","volume":"15","author":"Thompson","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2025.03.004_bib33","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/335645a0","article-title":"Rings of negatively charged amino acids determine the acetylcholine receptor channel conductance","volume":"335","author":"Imoto","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.cell.2025.03.004_bib34","doi-asserted-by":"crossref","first-page":"36066","DOI":"10.1074\/jbc.C800194200","article-title":"An Ion Selectivity Filter in the Extracellular Domain of Cys-loop Receptors Reveals Determinants for Ion Conductance","volume":"283","author":"Hansen","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cell.2025.03.004_bib35","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.cell.2025.03.004_bib36","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/0161-5890(95)00101-8","article-title":"Evidence for an antigen-driven selection process in human autoantibodies against acetylcholine receptor","volume":"32","author":"Cardona","year":"1995","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cell.2025.03.004_bib37","first-page":"695","article-title":"IMGT\/V-QUEST: IMGT Standardized Analysis of the Immunoglobulin (IG) and T Cell Receptor (TR) Nucleotide Sequences","volume":"2011","author":"Giudicelli","year":"2011","journal-title":"Cold Spring Harbor Protoc."},{"key":"10.1016\/j.cell.2025.03.004_bib38","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3390\/biom4041102","article-title":"Immunoglobulins: 25 Years of Immunoinformatics and IMGT-ONTOLOGY","volume":"4","author":"Lefranc","year":"2014","journal-title":"Biomolecules"},{"key":"10.1016\/j.cell.2025.03.004_bib39","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nature19785","article-title":"X-ray structure of the human \u03b14\u03b22 nicotinic receptor","volume":"538","author":"Morales-Perez","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cell.2025.03.004_bib40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0014-5793(83)80688-7","article-title":"Demonstration of a main immunogenic region on acetylcholine receptors from human muscle using monoclonal antibodies to human receptor","volume":"158","author":"Tzartos","year":"1983","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cell.2025.03.004_bib41","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1073\/pnas.77.2.755","article-title":"Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits","volume":"77","author":"Tzartos","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2025.03.004_bib42","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001169","article-title":"Heterogeneity of Acetylcholine Receptor Autoantibody\u2013Mediated Complement Activity in Patients With Myasthenia Gravis","volume":"9","author":"Obaid","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.cell.2025.03.004_bib43","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1073\/pnas.79.1.188","article-title":"Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies","volume":"79","author":"Tzartos","year":"1982","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2025.03.004_bib44","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1212\/WNL.39.8.1069","article-title":"Evidence against acetylcholine receptor having a main immunogenic region as target for autoantibodies in myasthenia gravis","volume":"39","author":"Lennon","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.cell.2025.03.004_bib45","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cca.2015.01.042","article-title":"An update on laboratory diagnosis in myasthenia gravis","volume":"444","author":"Oger","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cell.2025.03.004_bib46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0165-5728(88)90043-4","article-title":"Plasma from myasthenia gravis patients reduces acetylcholine receptor agonist-induced Na+ flux into TE671 cell line","volume":"19","author":"Lang","year":"1988","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.cell.2025.03.004_bib47","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.cell.2021.02.049","article-title":"Structure and gating mechanism of the \u03b17 nicotinic acetylcholine receptor","volume":"184","author":"Noviello","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cell.2025.03.004_bib48","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1073\/pnas.67.3.1241","article-title":"Use of a Snake Venom Toxin to Characterize the Cholinergic Receptor Protein","volume":"67","author":"Changeux","year":"1970","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2025.03.004_bib49","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJM198209233071301","article-title":"Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis","volume":"307","author":"Drachman","year":"1982","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2025.03.004_bib50","article-title":"Distribution and Temporal Changes of Autoantibody-Mediated Pathogenic Mechanisms among Acetylcholine Receptor-Positive Myasthenia Gravis Patients","author":"Khani-Habibabadi","year":"2024","journal-title":"medRxiv"},{"key":"10.1016\/j.cell.2025.03.004_bib51","doi-asserted-by":"crossref","first-page":"23S","DOI":"10.1212\/WNL.48.Suppl_5.23S","article-title":"Serologic profile of myasthenia gravis and distinction from the Lambert-Eaton myasthenic syndrome","volume":"48","author":"Lennon","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.cell.2025.03.004_bib52","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/jnnp-2019-322640","article-title":"Myasthenia gravis AChR antibodies inhibit function of rapsyn-clustered AChRs","volume":"91","author":"Cetin","year":"2020","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.cell.2025.03.004_bib53","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1016\/j.cell.2022.06.025","article-title":"Structural mechanisms of GABAA receptor autoimmune encephalitis","volume":"185","author":"Noviello","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.cell.2025.03.004_bib54","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1038\/s41594-024-01386-4","article-title":"Structural and functional mechanisms of anti-NMDAR autoimmune encephalitis","volume":"31","author":"Michalski","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.cell.2025.03.004_bib55","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1126\/science.aao4988","article-title":"Structures of C1-IgG1 provide insights into how danger pattern recognition activates complement","volume":"359","author":"Ugurlar","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.cell.2025.03.004_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-39788-5","article-title":"Complement is activated by elevated IgG3 hexameric platforms and deposits C4b onto distinct antibody domains","volume":"14","author":"Abendstein","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2025.03.004_bib57","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1006\/jmbi.1997.1508","article-title":"Crystallographic structure of an intact IgG1 monoclonal antibody11Edited","volume":"275","author":"Harris","year":"1998","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.cell.2025.03.004_bib58","article-title":"Structural Basis of Aquaporin-4 Autoantibody Binding in Neuromyelitis Optica","author":"Gupta","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.cell.2025.03.004_bib59","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1172\/JCI122942","article-title":"Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica","volume":"129","author":"Soltys","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.cell.2025.03.004_bib60","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/brain\/awz106","article-title":"Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production","volume":"142","author":"Cotzomi","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.cell.2025.03.004_bib61","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJM197805182982004","article-title":"Myasthenic Antibodies Cross-Link Acetylcholine Receptors to Accelerate Degradation","volume":"298","author":"Drachman","year":"1978","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2025.03.004_bib62","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.23043","article-title":"Structural insights into the molecular mechanisms of myasthenia gravis and their therapeutic implications","volume":"6","author":"Noridomi","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.cell.2025.03.004_bib63","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1021\/bi00511a017","article-title":"Monoclonal antibodies as probes of acetylcholine receptor structure. 2. Binding to native receptor","volume":"20","author":"Conti-Tronconi","year":"1981","journal-title":"Biochemistry"},{"key":"10.1016\/j.cell.2025.03.004_bib64","article-title":"Crosslinking-Induced Endocytosis of Acetylcholine Receptors by Quantum Dots","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cell.2025.03.004_bib65","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1152\/physrev.1984.64.4.1162","article-title":"Nicotinic receptor of acetylcholine: structure of an oligomeric integral membrane protein","volume":"64","author":"Popot","year":"1984","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cell.2025.03.004_bib66","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neuron.2007.06.031","article-title":"Rapsyn Interaction with Calpain Stabilizes AChR Clusters at the Neuromuscular Junction","volume":"55","author":"Chen","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.cell.2025.03.004_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135013","article-title":"Rapsyn as a signaling and scaffolding molecule in neuromuscular junction formation and maintenance","volume":"731","author":"Xing","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cell.2025.03.004_bib68","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0014-5793(86)80220-4","article-title":"Decrease in acetylcholine-receptor content of human myotube cultures mediated by monoclonal antibodies to \u03b1","volume":"196","author":"Tzartos","year":"1986","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cell.2025.03.004_bib69","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/jnc.14905","article-title":"Antibody-induced crosslinking and cholesterol-sensitive, anomalous diffusion of nicotinic acetylcholine receptors","volume":"152","author":"Mosqueira","year":"2020","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.cell.2025.03.004_bib70","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1083\/jcb.200709086","article-title":"Nicotinic acetylcholine receptor is internalized via a Rac-dependent, dynamin-independent endocytic pathway","volume":"181","author":"Kumari","year":"2008","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.cell.2025.03.004_bib71","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1212\/WNL.36.5.612","article-title":"Myasthenia gravis: Monoclonal antihuman acetylcholine receptor antibodies used to analyze antibody specificities and responses to treatment","volume":"36","author":"Whiting","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.cell.2025.03.004_bib72","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1212\/WNL.38.11.1784","article-title":"Anti-acetylcholine receptor antibody specificities in serum and in thymic cell culture supernatants from myasthenia gravis patients","volume":"38","author":"Heidenreich","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.cell.2025.03.004_bib73","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.410220205","article-title":"Acetylcholine receptors in human thymic myoid cells in\u00a0situ: an immunohistological study","volume":"22","author":"Schluep","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cell.2025.03.004_bib74","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jneuroim.2004.09.017","article-title":"Myasthenia gravis patients, but not healthy subjects, recognize epitopes that are unique to the epsilon-subunit of the acetylcholine receptor","volume":"159","author":"Ragheb","year":"2005","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.cell.2025.03.004_bib95","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ana.21802","article-title":"Intrathecal pathogenic anti\u2013aquaporin-4 antibodies in early neuromyelitis optica","volume":"66","author":"Bennett","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cell.2025.03.004_bib94","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"Tiller","year":"2008","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.cell.2025.03.004_bib79","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"Punjani","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cell.2025.03.004_bib83","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.cell.2025.03.004_bib84","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.cell.2025.03.004_bib86","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comp. Chem."},{"key":"10.1016\/j.cell.2025.03.004_bib91","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: Structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.cell.2025.03.004_bib85","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.cell.2025.03.004_bib90","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0263-7855(97)00009-X","article-title":"HOLE: A program for the analysis of the pore dimensions of ion channel structural models","volume":"14","author":"Smart","year":"1996","journal-title":"J.\u00a0Mol. Graphics"},{"key":"10.1016\/j.cell.2025.03.004_bib80","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1042\/BCJ20210708","article-title":"New tools for automated cryo-EM single-particle analysis in RELION-4.0.","volume":"478","author":"Kimanius","year":"2021","journal-title":"Biochem. J."},{"key":"10.1016\/j.cell.2025.03.004_bib82","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-024-07215-4","article-title":"Automated model building and protein identification in cryo-EM maps","volume":"628","author":"Jamali","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.cell.2025.03.004_bib75","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.str.2006.01.013","article-title":"Fluorescence-detection size-exclusion chromatography for precrystallization screening of integral membrane proteins","volume":"14","author":"Kawate","year":"2006","journal-title":"Structure"},{"key":"10.1016\/j.cell.2025.03.004_bib76","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/biot.201400821","article-title":"Optimized Sleeping Beauty transposons rapidly generate stable transgenic cell lines","volume":"10","author":"Kowarz","year":"2015","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.cell.2025.03.004_bib77","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s101260000072","article-title":"Effects of Insert Size on Transposition Efficiency of the Sleeping Beauty Transposon in Mouse Cells","volume":"3","author":"Karsi","year":"2001","journal-title":"Mar. Biotechnol. (NY)"},{"key":"10.1016\/j.cell.2025.03.004_bib78","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ng.343","article-title":"Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates","volume":"41","author":"M\u00e1t\u00e9s","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cell.2025.03.004_bib81","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41592-020-00990-8","article-title":"Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction","volume":"17","author":"Punjani","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cell.2025.03.004_bib87","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nbt.2797","article-title":"Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface","volume":"32","author":"Lewis","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cell.2025.03.004_bib88","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s42003-021-02399-1","article-title":"DeepEMhancer: a deep learning solution for cryo-EM volume post-processing","volume":"4","author":"Sanchez-Garcia","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.cell.2025.03.004_bib89","first-page":"3.13.1","article-title":"Clustal Omega","volume":"48","author":"Sievers","year":"2014","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.cell.2025.03.004_bib92","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1021\/ac950914h","article-title":"Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels","volume":"68","author":"Shevchenko","year":"1996","journal-title":"Anal. Chem."},{"key":"10.1016\/j.cell.2025.03.004_bib93","article-title":"AIRR-C IG Reference Sets: curated sets of immunoglobulin heavy and light chain germline genes","volume":"14","author":"Collins","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2025.03.004_bib96","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/nprot.2016.102","article-title":"Sequencing and cloning of antigen-specific antibodies from mouse memory B cells","volume":"11","author":"von Boehmer","year":"2016","journal-title":"Nat. Protoc."}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867425002776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867425002776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:44:14Z","timestamp":1773870254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867425002776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":96,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0092867425002776"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2025.03.004","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.12.18.629229","asserted-by":"object"}]},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune mechanisms elucidated through muscle acetylcholine receptor structures","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2025.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}